Your session is about to expire
← Back to Search
Other
3 for Head Lice
Phase 2
Waitlist Available
Led By Dyal Garg, Ph.D.
Research Sponsored by ParaPRO LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
A pilot dose ranging study to evaluate the safety and efficacy of different strengths of Spinosad Creme versus a vehicle control.
Eligible Conditions
- Head Lice
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
4Treatment groups
Active Control
Placebo Group
Group I: 3Active Control1 Intervention
1.0% Spinosad Creme Rinse
Group II: 2Active Control1 Intervention
0.5% Spinosad creme rinse
Group III: 4Active Control1 Intervention
2.0% Spinosad Creme Rinse
Group IV: 1Placebo Group1 Intervention
Vehicle control
Find a Location
Who is running the clinical trial?
ParaPRO LLCLead Sponsor
11 Previous Clinical Trials
1,937 Total Patients Enrolled
Dyal Garg, Ph.D.Principal InvestigatorHill Top Research
Share this study with friends
Copy Link
Messenger